Skip to main content
BioNote, Inc. logo

BioNote, Inc. — Investor Relations & Filings

Ticker · 377740 ISIN · KR7377740006 KO Manufacturing
Filings indexed 162 across all filing types
Latest filing 2026-05-29 Director's Dealing
Country KR South Korea
Listing KO 377740

About BioNote, Inc.

https://www.bionote.com/

BioNote, Inc. is a company specializing in in-vitro diagnostics for the animal health industry. It develops, manufactures, and distributes a range of veterinary diagnostic products, including rapid test kits, ELISA kits, point-of-care (POC) analyzers, and biomarker tests. The company's portfolio is based on its research and development of core biological components like antigens and antibodies. Its products are designed for the detection and diagnosis of animal diseases, providing veterinarians with tools for immunochemical and quantitative analysis in clinical settings.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a statutory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing an officer’s (director’s) shareholdings and insider transactions (e.g., 장내매수) filed with the Financial Services Commission and Korea Exchange. It is not a general financial report but an insider dealing report. This matches the “Director's Dealing” category (DIRS).
2026-05-29 Korean
기업지배구조보고서공시
Governance Information Classification · 95% confidence The document is a detailed corporate governance report (“기업지배구조보고서”) containing extensive information on board structure, governance policies, audit committee operations, shareholder meeting procedures and compliance with governance principles. It is not an announcement or proxy solicitation, nor a financial statement or earnings release, but rather a full governance disclosure. This matches the “Governance Information” category (CGR).
2026-05-29 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 94% confidence The document is titled "분기보고서 (제 24 기) 2026년 01월 01일 ~ 2026년 03월 31일", which is the company’s formal quarterly report filed with the Financial Supervisory Service and Korea Exchange. It contains substantive financial data (capital changes, segment sales, production figures, business overview, etc.) for the first quarter of 2026, fulfilling the criteria for an Interim / Quarterly Report. Therefore, it should be classified as IR. Q1 2026
2026-05-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 92% confidence The document is a Korean ‘fair disclosure’ of preliminary consolidated financial results for Q1 (2026.01.01–2026.03.31), showing key metrics (revenue, operating profit, net profit) and noting its tentative nature pending audit. It is an initial announcement of periodical financial results (a typical quarterly earnings release), not a full interim report or the formal annual report. Hence it fits the Earnings Release category. Q1 2026
2026-05-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 85% confidence The document is a Korean regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” which translates to a report on the holdings and changes of certain securities by officers and major shareholders. It details an officer (Kim Il Jung) and his acquisition of 160,000 shares via stock option exercise, including dates, quantities, price, and ownership percentages. This is exactly the type of insider transaction/holding disclosure by company directors or executives. Therefore, it fits the “Director's Dealing (DIRS)” category.
2026-04-21 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 98% confidence The document is a ‘최대주주등소유주식변동신고서’, i.e. a report on changes in the major shareholder’s share ownership. It provides detailed tables of shareholdings before and after the change, along with individual insider transactions. This matches the “Major Shareholding Notification” category (MRQ).
2026-04-21 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.